303 related articles for article (PubMed ID: 31033184)
21. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.
Ramírez SP; Carvajal AC; Salazar JC; Arroyave G; Flórez AM; Echeverry HF
J Drugs Dermatol; 2013 Jun; 12(6):e106-10. PubMed ID: 23839199
[TBL] [Abstract][Full Text] [Related]
22. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial.
Leenutaphong V; Nettakul A; Rattanasuwon P
J Med Assoc Thai; 1999 Sep; 82(9):868-75. PubMed ID: 10561942
[TBL] [Abstract][Full Text] [Related]
23. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
Kaufman BP; Alexis AF
J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of the safety and efficacy of 75% mulberry (Morus alba) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial.
Alvin G; Catambay N; Vergara A; Jamora MJ
J Drugs Dermatol; 2011 Sep; 10(9):1025-31. PubMed ID: 22052272
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a health-related quality of life instrument for women with melasma.
Balkrishnan R; McMichael AJ; Camacho FT; Saltzberg F; Housman TS; Grummer S; Feldman SR; Chren MM
Br J Dermatol; 2003 Sep; 149(3):572-7. PubMed ID: 14510991
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.
Nagaraju D; Bhattacharjee R; Vinay K; Saikia UN; Parsad D; Kumaran MS
Dermatol Ther; 2018 Sep; 31(5):e12704. PubMed ID: 30253023
[TBL] [Abstract][Full Text] [Related]
27. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
28. Clinical Efficacy and Safety on Combining 20% Trichloroacetic Acid Peel with Topical 5% Ascorbic Acid for Melasma.
Dayal S; Sahu P; Yadav M; Jain VK
J Clin Diagn Res; 2017 Sep; 11(9):WC08-WC11. PubMed ID: 29207818
[TBL] [Abstract][Full Text] [Related]
29. Melasma: The need for tailored photoprotection to improve clinical outcomes.
Morgado-Carrasco D; Piquero-Casals J; Granger C; Trullàs C; Passeron T
Photodermatol Photoimmunol Photomed; 2022 Nov; 38(6):515-521. PubMed ID: 35229368
[TBL] [Abstract][Full Text] [Related]
30. Disease characteristics, determinants, and perception of use of sunscreen and sun-protective behaviors among patients of color with melasma: A cross-sectional study.
Seetan K; Shatanawi M; Ali A; Khamees A; Alsheikh A; Alawneh A; Al-Shami M; Al-Shar'e H
Photodermatol Photoimmunol Photomed; 2022 Sep; 38(5):495-500. PubMed ID: 35108414
[TBL] [Abstract][Full Text] [Related]
31. [Photoprotection, melasma and quality of life in pregnant women].
Purim KS; Avelar MF
Rev Bras Ginecol Obstet; 2012 May; 34(5):228-34. PubMed ID: 22584858
[TBL] [Abstract][Full Text] [Related]
32. Psychometrican analysis and dimensional structure of the Brazilian version of melasma quality of life scale (MELASQoL-BP).
Maranzatto CF; Miot HA; Miot LD; Meneguin S
An Bras Dermatol; 2016; 91(4):422-8. PubMed ID: 27579735
[TBL] [Abstract][Full Text] [Related]
33. Most worthwhile superficial chemical peel for melasma of skin of color: Authors' experience of glycolic, trichloroacetic acid, and lactic peel.
Sahu P; Dayal S
Dermatol Ther; 2021 Jan; 34(1):e14693. PubMed ID: 33372385
[TBL] [Abstract][Full Text] [Related]
34. Salicylic acid for the treatment of melasma: new acquisitions for monitoring the clinical improvement.
Fabbrocini G; De Vita V; Marasca C; Palmisano F; Monfrecola G
Skin Res Technol; 2013 Nov; 19(4):466-73. PubMed ID: 23527534
[TBL] [Abstract][Full Text] [Related]
35. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma.
Figueiredo Souza L; Trancoso Souza S
Dermatol Ther; 2012; 25(5):477-80. PubMed ID: 23046029
[TBL] [Abstract][Full Text] [Related]
36. Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: A comparative study.
Balevi A; Ustuner P; Özdemir M
J Cosmet Laser Ther; 2017 Oct; 19(5):294-299. PubMed ID: 28388246
[TBL] [Abstract][Full Text] [Related]
37. Topical 10% zinc sulfate solution for treatment of melasma.
Sharquie KE; Al-Mashhadani SA; Salman HA
Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534
[TBL] [Abstract][Full Text] [Related]
38. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
39. Treatment of melasma with platelet-rich plasma: A self-controlled clinical trial.
González-Ojeda A; Cervantes-Guevara G; Chejfec-Ciociano JM; Cervantes-Cardona GA; Acevedo-Guzman D; Puebla-Mora AG; Cortés-Lares JA; Chávez-Tostado M; Álvarez-Villaseñor AS; Cervantes-Pérez E; Ramos-Álvarez MP; Pacheco-Vallejo LR; Barbosa-Camacho FJ; Fuentes-Orozco C
Dermatol Ther; 2022 Sep; 35(9):e15703. PubMed ID: 35831241
[TBL] [Abstract][Full Text] [Related]
40. Microneedling with Drug Delivery (Hydroquinone 4% Serum) as an Adjuvant Therapy for Recalcitrant Melasma.
Ramírez-Oliveros JF; de Abreu L; Tamler C; Vilhena P; de Barros MH
Skinmed; 2020; 18(1):38-40. PubMed ID: 32167455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
